Kiniksa Pharmaceuticals International
- Market cap
- 6.08B
- P/E (TTM)i
- 78.75
- P/Bi
- 9.30
- EPSi
- 0.75
- Div yieldi
- 0.00%
- 52W posi
- 90%
Anonymous reader poll. Unscientific, not investment advice.
Kiniksa Pharmaceuticals International last traded at 77.96, up 1.13% on the session. Its market capitalisation is about 6.08B, the #1938 most valuable US-listed company we track. Valuation-wise, the P/E sits at 76.62, 221% above the five-year average of 23.85. Across 7 analysts the consensus rating is Buy, with an average price target of 96.57 (+24%). Against a 52-week band of 35.20-82.94, the shares are currently 90% of the way up.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 6% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Its last 5 Buy calls have averaged +17% over the following quarter.
- Recent price momentum is +60.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 5.0% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 77.09
- Open
- 76.18
- Day range
- 74.70 - 79.22
- Avg price
- 77.96
- Volume
- 381.05K
- Turnover
- 29.71M
- Turnover ratei
- 0.96%
- Volume ratioi
- 0.71
- Amplitudei
- 5.86%
- 52-week rangei
- 35.20 - 82.94
Valuation
- P/Ei
- 103.95
- P/E (TTM)i
- 78.75
- P/Bi
- 9.30
- EPSi
- 0.75
- Book value / shi
- 8.38
- Net profit
- 58.52M
- Net assets
- 654.15M
Share structure
- Market cap
- 6.08B
- Float capi
- 3.11B
- Shares out
- 78.02M
- Float sharesi
- 39.86M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2018-05-24
6.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-6.69M net over the window
Short interest
- Shares short
- 3.88M
- % of floati
- 4.97%
- Days to coveri
- 7.21
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Kiniksa Pharmaceuticals International (KNSA)?
Kiniksa Pharmaceuticals International last traded at 77.96. The quote on this page refreshes every few seconds while US markets are open.
What is Kiniksa Pharmaceuticals International's market cap?
About 6.08B.
What is the P/E ratio of Kiniksa Pharmaceuticals International?
The trailing twelve-month P/E is 78.75, above its own 5-year average of 23.85 — toward the top of its historical range (77.41% percentile). See the Valuation tab for the full history.
Does Kiniksa Pharmaceuticals International pay a dividend?
Kiniksa Pharmaceuticals International does not currently pay a regular dividend.
Is Kiniksa Pharmaceuticals International a buy according to analysts?
The consensus of 7 analysts is a Buy rating, with an average 12-month price target of 96.57, which implies 23.9% upside from the current price. This is not investment advice.
What is Kiniksa Pharmaceuticals International's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Kiniksa Pharmaceuticals International a B (Buy). Twelve-month momentum in the top 6% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.